Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in <i>p53</i>
Gemma L. Kelly(The University of Melbourne), Andreas Strasser(The University of Melbourne)
Cited by 169
Related Papers
The BCL-2 protein family, BH3-mimetics and cancer therapy
|Cell Death and Differentiation|2015|540
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
|Genes & Development|2012|417
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
|Cell Death and Differentiation|2019|61
RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice
|The Journal of Experimental Medicine|2016|16